Drug delivery device having improved needle cover

JP2024544389AInactive Publication Date: 2024-11-29SANOFI SA(FR)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024535733
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-15
Filing Date
2022-12-13
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing drug delivery devices, particularly autoinjectors and semi-automated devices, face challenges in ease of use and comfort, especially when administering injections to children, often requiring removable needles or different container types which can be cumbersome.

Method used

A drug delivery device design featuring a housing with a distal device portion that includes a needle cover with a distal opening, an intermediate portion, and a proximal portion, where the needle is hidden until injection, allowing for a bearing surface for easy skin contact and improved visibility and access during injection, and utilizing movable or elastic needle covers for enhanced usability.

Benefits of technology

The design enhances ease of use and comfort by providing a hidden needle mechanism, improved visibility, and reduced risk of accidental needle sticks, making injections easier and safer, especially for children.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024544389000001_ABST
    Figure 2024544389000001_ABST
Patent Text Reader

Abstract

A drug delivery device (100-800) comprising a housing (102) extending along a longitudinal axis (A) of the drug delivery device (100-800) and a distal device portion (DDP), the distal device portion (DDP) comprising a distal portion (DP), a proximal portion (PP) and at least one intermediate portion (IP), the distal portion (DP) comprising a distal opening (370) allowing passage of a needle (210) and a bearing surface (BF), the bearing surface (BF) being configured to be pressed against the patient's skin (220) during injection of a drug (Dr), and the intermediate portion (IP) being configured to be pressed against the patient's skin (220) during injection of a drug (Dr), Disclosed is a drug delivery device (100-800), wherein the portion (IP) comprises at least one wall portion extending proximally from the distal portion (DP) to the proximal portion (PP), and in at least one state of the drug delivery device (100-800), a first radial outer dimension (D3a) of the distal portion (DP) in a region axially adjacent to the bearing surface (BF) is smaller than a second radial outer dimension (D3b) of the intermediate portion (IP), and an outer surface of the intermediate portion (IP) is inclined (An4) with respect to the longitudinal axis (A) in a cross section along the longitudinal axis (A).
Need to check novelty before this filing date? Find Prior Art